stockrowPrivia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +83.3%
- Free cash flow
- −44.4%
Quarter to September 2026, against a year earlier
Follow PRVA
Alert me
Privia Health Group, Inc. (PRVA) EBITDA
Privia Health Group, Inc.'s EBITDA for fiscal 2025 was $44.1M, up 82.0% from $24.3M in fiscal 2024. Over the twelve months to 30 September 2026 it was $63.8M. Over the past ten years it has ranged from −$214.8M (fiscal 2021) to $44.1M (fiscal 2025) — the current reading is the highest in ten years. Privia Health Group, Inc. ranks 14th of 43 Health Information Services companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $44.1M | 82.03% |
| FY2024 | $24.3M | (10.79%) |
| FY2023 | $27.2M | — |
| FY2022 | −$13.9M | — |
| FY2021 | −$214.8M | — |
| FY2020 | $27.3M | 53.44% |
| FY2019 | $17.8M | 494.03% |
| FY2018 | $3.0M | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $24.0M | 58.93% |
| Jun 2026 | $15.1M | 41.35% |
| Mar 2026 | $10.7M | (23.19%) |
| Dec 2025 | $13.9M | (18.84%) |
| 23 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| WAY Waystar Holding Corp. compare | $444.3M |
| DOCS Doximity, Inc. compare | $218.1M |
| TDOC Teladoc Health, Inc. compare | $214.9M |
| GDRX GoodRx Holdings, Inc. compare | $165.4M |
| OMCL Omnicell, Inc. compare | $144.5M |
| CERT Certara, Inc. compare | $78.0M |
| PRVA Privia Health Group, Inc. | $63.8M |
| HTFL Heartflow, Inc. compare | −$72.7M |
| SDGR Schrodinger, Inc. compare | −$127.8M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on PRVA
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement